D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.2B |
| 2 |
NVIDIA
NVDA
|
+$1.02B |
| 3 |
T-Mobile US
TMUS
|
+$911M |
| 4 |
Netflix
NFLX
|
+$699M |
| 5 |
Micron Technology
MU
|
+$672M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$768M |
| 2 |
Robinhood
HOOD
|
+$643M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$534M |
| 4 |
Microsoft
MSFT
|
+$493M |
| 5 |
Intuit
INTU
|
+$472M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.33% |
| 2 | Healthcare | 8.66% |
| 3 | Consumer Discretionary | 8.33% |
| 4 | Financials | 6.44% |
| 5 | Industrials | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Employers Holdings
EIG
$907M
| $4.54M | ﹤0.01% |
96,153
+19,716
| +26% | +$951K |
|
|
TVA
2002
Texas Ventures Acquisition III Corp
TVA
$315M
| $4.54M | ﹤0.01% |
+450,000
| New | +$4.52M |
|
2003
Banco Bradesco
BBD
$37.4B
| $4.53M | ﹤0.01% |
1,467,030
-18,844,229
| -93% | -$49.6M |
|
2004
Medifast
MED
$107M
| $4.51M | ﹤0.01% |
321,229
-12,217
| -4% | -$161K |
|
2005
First Internet Bancorp
INBK
$233M
| $4.5M | ﹤0.01% |
167,357
+40,184
| +32% | +$958K |
|
2006
Ameris Bancorp
ABCB
$5.89B
| $4.49M | ﹤0.01% |
69,470
-43,732
| -39% | -$2.59M |
|
|
OPFI.WS
2007
DELISTED
OppFi Inc Warrants
OPFI.WS
| $4.49M | ﹤0.01% |
1,049,673
| – | – |
|
2008
PUT
TFI International
TFII
$11.6B
| $4.49M | ﹤0.01% |
50,000
| – | – |
|
2009
CALL
Ares Capital
ARCC
$13.4B
| $4.49M | ﹤0.01% |
204,300
+184,400
| +927% | +$3.92M |
|
2010
BrightView Holdings
BV
$1.24B
| $4.47M | ﹤0.01% |
268,254
+15,953
| +6% | +$239K |
|
|
KREF
2011
KKR Real Estate Finance Trust
KREF
$466M
| $4.46M | ﹤0.01% |
508,960
+103,853
| +26% | +$956K |
|
2012
EnerSys
ENS
$6.43B
| $4.46M | ﹤0.01% |
51,991
-140,474
| -73% | -$12.2M |
|
2013
CALL
AstraZeneca
AZN
$269B
| $4.46M | ﹤0.01% |
31,900
+30,450
| +2,100% | +$4.27M |
|
2014
ANI Pharmaceuticals
ANIP
$1.86B
| $4.46M | ﹤0.01% |
68,292
-161,409
| -70% | -$10.5M |
|
2015
BWX Technologies
BWXT
$14.4B
| $4.45M | ﹤0.01% |
30,867
-73,275
| -70% | -$8.56M |
|
2016
Xenon Pharmaceuticals
XENE
$6.1B
| $4.44M | ﹤0.01% |
141,783
-10,405
| -7% | -$339K |
|
2017
PubMatic
PUBM
$608M
| $4.43M | ﹤0.01% |
356,381
-95,529
| -21% | -$1.01M |
|
2018
PUT
Nutanix
NTNX
$16.1B
| $4.42M | ﹤0.01% |
57,800
+14,700
| +34% | +$1.06M |
|
2019
Douglas Elliman
DOUG
$156M
| $4.4M | ﹤0.01% |
1,895,396
+252,039
| +15% | +$538K |
|
2020
ProPetro Holding
PUMP
$1.25B
| $4.38M | ﹤0.01% |
733,249
+244,745
| +50% | +$1.4M |
|
2021
White Mountains Insurance
WTM
$5.33B
| $4.37M | ﹤0.01% |
2,436
+78
| +3% | +$139K |
|
2022
Main Street Capital
MAIN
$5.05B
| $4.37M | ﹤0.01% |
73,957
+65,643
| +790% | +$3.63M |
|
|
TGB
2023
Trekor Metals
TGB
$2.45B
| $4.37M | ﹤0.01% |
1,387,211
-372,790
| -21% | -$872K |
|
2024
RH
RH
$3.33B
| $4.37M | ﹤0.01% |
+23,104
| New | +$4.29M |
|
2025
PUT
IBM
IBM
$213B
| $4.36M | ﹤0.01% |
14,800
-136,900
| -90% | -$35.3M |
|
Similar funds
D.E. Shaw & Co's Q2 2025 Portfolio in Review
As of Q2 2025, D.E. Shaw & Co held 4,838 positions worth $141B, up 26% from $112B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co deployed $7.51B of net new capital in Q2 2025, opening 647 new positions and adding to 1,556 existing holdings. Its largest new stake was Sea Limited: 1,365,221 shares worth $218M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was GE Vernova, an estimated $768M trimmed.
- D.E. Shaw & Co's largest Q2 2025 buy was Sea Limited: 1,365,221 shares worth $218M.
- D.E. Shaw & Co added most to Apple in Q2 2025, an estimated $1.2B increase.
- D.E. Shaw & Co's biggest Q2 2025 reduction was GE Vernova, cutting an estimated $768M.
- D.E. Shaw & Co fully exited Novo Nordisk in Q2 2025, selling an estimated $176M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $141B portfolio in Q2 2025.
- D.E. Shaw & Co opened 647 new positions and closed 532 in Q2 2025.
- D.E. Shaw & Co's portfolio value rose 26% quarter-over-quarter to $141B.
Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.